Marieke Krol

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer
    Marieke Krol
    Institute for Medical Technology Assessment, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Expert Opin Pharmacother 8:1313-28. 2007
  2. doi request reprint Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Value Health 12:172-80. 2009
  3. ncbi request reprint Productivity costs in economic evaluations: past, present, future
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Pharmacoeconomics 31:537-49. 2013
  4. ncbi request reprint Productivity costs in health-state valuations : does explicit instruction matter?
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Pharmacoeconomics 24:401-14. 2006
  5. doi request reprint Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands
    Soc Sci Med 75:1981-8. 2012
  6. doi request reprint Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands
    Pharmacoeconomics 29:601-19. 2011
  7. ncbi request reprint Predicting productivity based on EQ-5D: an explorative study
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Health Econ 15:465-75. 2014
  8. ncbi request reprint How to estimate productivity costs in economic evaluations
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Pharmacoeconomics 32:335-44. 2014
  9. ncbi request reprint Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study
    Luciana Scalone
    CIRFF Centre of Pharmacoeconomics, University of Naples Federico II, Naples, Italy CHARTA Foundation member of COPERA, Milan, Italy
    Curr Med Res Opin 24:1905-17. 2008

Detail Information

Publications9

  1. ncbi request reprint A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer
    Marieke Krol
    Institute for Medical Technology Assessment, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Expert Opin Pharmacother 8:1313-28. 2007
    ..These studies are preferably performed by taking a societal perspective and including quality of life outcomes...
  2. doi request reprint Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Value Health 12:172-80. 2009
    ..Moreover, it tests the consequences of explicit instructions to include or exclude income effects...
  3. ncbi request reprint Productivity costs in economic evaluations: past, present, future
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Pharmacoeconomics 31:537-49. 2013
    ..More standardization would increase the comparability and credibility of economic evaluations taking a societal perspective. ..
  4. ncbi request reprint Productivity costs in health-state valuations : does explicit instruction matter?
    Marieke Krol
    Department of Health Policy and Management, Erasmus University Erasmus MC, Rotterdam, The Netherlands
    Pharmacoeconomics 24:401-14. 2006
    ..At the moment, little is known about whether the effects of ill health on income are included in health-state valuations, and how instructions on including or excluding the effects on income influence health-state valuations...
  5. doi request reprint Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands
    Soc Sci Med 75:1981-8. 2012
    ..Productivity costs estimates are strongly influenced by adjustment for compensation mechanisms and multiplier effects. The validity of such adjustments needs further examination, however...
  6. doi request reprint Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands
    Pharmacoeconomics 29:601-19. 2011
    ..This may considerably bias the results of cost-effectiveness studies, particularly those regarding treatments targeted at diseases with a high incidence rate in the working population, such as depressive disorders...
  7. ncbi request reprint Predicting productivity based on EQ-5D: an explorative study
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Health Econ 15:465-75. 2014
    ..Productivity costs are often ignored in economic evaluations. In order to facilitate productivity cost inclusion, it has been suggested to estimate productivity costs indirectly using quality of life data...
  8. ncbi request reprint How to estimate productivity costs in economic evaluations
    Marieke Krol
    Department of Health Policy and Management, Erasmus University, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Pharmacoeconomics 32:335-44. 2014
    ..We indicate how to apply the friction cost and the human capital approach and give practical guidance on deriving final cost estimates. ..
  9. ncbi request reprint Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study
    Luciana Scalone
    CIRFF Centre of Pharmacoeconomics, University of Naples Federico II, Naples, Italy CHARTA Foundation member of COPERA, Milan, Italy
    Curr Med Res Opin 24:1905-17. 2008
    ..The purpose was to estimate the societal burden attributable to beta-TM in terms of direct and indirect costs, health-related quality-of-life (HRQoL), satisfaction and compliance with ICT in patients undergoing transfusions and ICT...